ESC Premium Access

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts - the BiomarCaRE project.

Congress Presentation

About the speaker

Professor Dietrich Rothenbacher

University of Ulm, Ulm (Germany)
0 follower

4 more presentations in this session

Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study

Speaker: Doctor H. Lee (Seoul, KR)


Beta-blocker treatment in atrial fibrillation with chronic obstructive pulmonary disease: a Danish nationwide study from 1995 to 2015

Speaker: Mr C. Benson (Copenhagen, DK)


Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

Speaker: Doctor S. Lee (Seoul, KR)


Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr P. Nielsen (Aalborg, DK)


Access the full session

Atrial fibrillation: risks and management

Speakers: Professor D. Rothenbacher, Doctor H. Lee, Mr C. Benson, Doctor S. Lee, Mr P. Nielsen

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb